Dr. Explains Why Retatrutide is KING of Fat Loss Peptides
This Is Not Covered — Dr. Ashley Froese — Dr. Explains Why Retatrutide is KING of Fat Loss Peptides
Channel: This Is Not Covered - Dr. Ashley Froese · Our label: Clinician educator · Source: youtube.com/watch?v=ukCySPXN0WU
What this video covers
Can you do just a little and come off of it later? Well, today I’ve got all the answers to those questions and more. So, there’s no room for confusion, no holding back. And just as a quick disclaimer, this is not medical advice from me to you.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- So first just for clarity sake you need to know the difference between the GLP injectables and why retatriutide has become the king of GLPs.
- The long and short of it is that we now have good better best versions of a weight loss peptide blend that not only blunts your appetite and decreases inflammation and insulin resistance but now increases your metabolism.
- It’s a peptide blend of GLP, GIP, and glucagon receptor agonism.
- With GLP-1, we went from 15% average weight loss in the studies to 20 to 25% weight loss on the studies on tzeptide or GLP-1 plus GIP.
- But speaking of safety, in a controlled clinical setting, it’s been proven to be safe, but safe doesn’t mean side effect-free.
- What we’ve seen in the clinical trials so far is that up to 40% of weight lost on these GLP agonist peptide blends can be lean mass or muscle.
Read next
- GLP-1 class — more videos
- Semaglutide — more videos
- Retatrutide — more videos
- All videos from this channel
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.